Opinion|Videos|March 24, 2025
The Role of Prevention in the Management of Atherosclerotic Disease and Aortic Stenosis
Experts discuss the clinical and economic burden of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis in the US, exploring their impact on health care systems, the importance of prevention in reducing this burden, and the challenges of implementing preventive strategies, while considering the potential benefits of improved risk assessment and prevention in the ASCVD space.
Advertisement
Video content above is prompted by the following:
- Please describe the clinical and economic burden of atherosclerotic cardiovascular disease—or ASCVD—and aortic stenosis in the US today.
- How do these diseases impact health systems like the ones you work with?
- What role does prevention play in mitigating this burden?
- Adherence to preventive regimens can be difficult for patients. On a population level, do the challenges of implementing preventive ASCVD strategies outweigh the benefits? Is there a place for better risk assessment and prevention in the ASCVD space?
Advertisement
Related to this article
ApoB more directly reflects atherogenic particle burden than LDL-C, but missing outcome trials and assay variability still limit its routine use.
Advertisement
Advertisement
Trending on AJMC
1
Pathological Response Does Not Reliably Predict Survival in Sarcoma
2
5 Things to Know About the One Big Beautiful Bill Act
3
New CHEST Guidelines Offer a Road Map for Bronchiectasis
4
CHEST Investigations Explore COPD Guideline Adherence, Adding Ensifentrine, and Use of AI in Education
5